Ionamin 15 mg Order Online
Ionamin Capsules are indicated only
as short-term monotherapy for the management of exogenous obesity. The
safety and efficacy of combination therapy with phentermine and any
other drug products for weight loss, including selective serotonin
reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine,
paroxetine), have not been established. Therefore, Ionamin 15 mg Order Online the coadministration
of these drug products for weight loss is not recommended.
Primary Pulmonary Hypertension (PPH) – a rare,
frequently fatal disease of the lungs – has been reported to occur in
patients receiving a combination of phentermine with fenfluramine or
dexfenfluramine. The possibility Ionamin 15 mg Order Online of an association between PPH and the
use of phentermine alone cannot be ruled out. The initial symptom
of PPH is usually dyspnea. Other initial symptoms include: angina
pectoris, syncope, or lower extremity edema. Patients should be advised
to report immediately any deterioration in exercise tolerance. Treatment
should be discontinued in patients who develop new, unexplained
symptoms of dyspnea, angina Ionamin 15 mg Order Online pectoris, syncope, or lower extremity edema.
Valvular Heart Disease+Buy Ionamin Capsule
Serious Buy Ionamin Capsule regurgitant cardiac valvular
disease, primarily affecting the mitral, aortic and/or tricuspid
valves, has been reported in otherwise healthy persons who had taken a
combination of phentermine with fenfluramine or Buy Ionamin Capsule dexfenfluramine for
weight loss. The etiology of these valvulopathies has not been
established and their course in individuals after the drugs are stopped
is not known.
If tolerance to the “anorectic” effect develops, the recommended dose
should not be exceeded in an attempt to increase the effect: rather,
the drug should be discontinued buy Ionamin Capsule .
Ionamin may impair the ability of the patient to engage in
potentially hazardous activities such as operating machinery or driving a
motor vehicle; the patient should therefore be cautioned accordingly.
When using CNS active agents, consideration must always be given to the possibility of adverse interactions with alcohol.
Drug Ionamin 15 mg Order Online Dependence
Ionamin 15 mg Order Online is related chemically and pharmacologically to amphetamine (d- and dl-amphetamine)
and other stimulant drugs that have been extensively abused. The
possibility Ionamin 15 mg Order Online of abuse of Ionamin should be kept in mind when evaluating
the desirability of including a drug as part of a weight reduction
program. Abuse of amphetamine (d- and dl-amphetamine)
and related drugs may be associated with intense psychological
dependence and severe social dysfunction. There Ionamin 15 mg Order Online are reports of patients
who have increased the dosage of some of these drugs to many times that
recommended. Abrupt cessation following prolonged high dosage
administration results in extreme fatigue and mental depression;Ionamin 15-30 mg order online changes
are also noted on the sleep EEG. Manifestations of chronic intoxication
with anorectic drugs include severe dermatoses, marked insomnia,
irritability, hyperactivity, and personality changes. The most severe
manifestation of chronic intoxications is psychosis, often clinically
indistinguishable from Ionamin 15 mg Order Online schizophrenia.
Usage in Pregnancy
Safe use in pregnancy has not been established. Use of
Ionamin by women who are or may become pregnant requires that the
potential benefit be weighed against the possible hazard to mother and
Ionamin Capsules (phentermine resin) are not recommended for use in pediatric patients under 16 years of age.
Caution is to be exercised in prescribing Ionamin for
patients with even mild hypertension. Insulin requirements in diabetes
mellitus may be altered in association with the use of Ionamin and the
concomitant dietary regimen.
Ionamin may decrease the hypotensive effect of adrenergic neuron blocking drugs.
The least amount feasible should be prescribed or dispensed at one time in order to minimize the possibility of overdosage.
Clinical studies of Ionamin did not include sufficient
numbers of subjects aged 65 or over to determine whether they respond
differently from younger subjects. Other reported clinical experience
has not identified differences in responses between the elderly and
younger patients. In general, dose selection for an elderly patient
should be cautious, usually starting at the low end of the dosing range,
reflecting the greater frequency of decreased hepatic, renal, or
cardiac function, and of concomitant disease or other drug therapy.
This drug is known to be substantially excreted by the kidney, and
the risk of toxic reactions to this drug may be greater in patients with
impaired renal function. Because elderly patients are more likely to
have decreased renal function, care should be taken in dose selection,
and it may be useful to monitor renal function.
Primary pulmonary hypertension (see WARNINGS), palpitation, tachycardia, elevation of blood pressure.
Central Nervous System
Overstimulation, restlessness, dizziness, insomnia,
euphoria, dysphoria, tremor, headache; rarely psychotic episodes at
recommended doses with some drugs in this class.
Dryness of the mouth, unpleasant taste, diarrhea, constipation, other gastrointestinal disturbances.
Impotence, changes in libido.